Literature DB >> 6345685

Localization of eosinophil granule major basic protein in chronic urticaria.

M S Peters, A L Schroeter, G M Kephart, G J Gleich.   

Abstract

The role of the eosinophil in the pathogenesis of cutaneous diseases is not known. The eosinophil granule major basic protein (MBP), constituting the core and accounting for greater than 50% of the eosinophil granule, is toxic to helminths and mammalian cells. To determine whether eosinophil degranulation occurs in lesions of chronic urticaria, we performed an indirect immunofluorescence assay on sections of formalin-fixed, paraffin-embedded tissue, utilizing affinity chromatography-purified antibody to MBP. Twelve of 28 biopsies showed evidence of degranulation as judged by the deposition of MBP outside the eosinophil. The positive staining was of 3 types: (1) small blood vessel walls (5 patients), (2) dispersion of granular material (9 patients), and (3) focal or diffuse immunofluorescence of connective tissue fibers (11 patients). These results suggest a possible role for the cytotoxic molecule MBP in the evolution of lesions of chronic urticaria.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6345685     DOI: 10.1111/1523-1747.ep12538380

Source DB:  PubMed          Journal:  J Invest Dermatol        ISSN: 0022-202X            Impact factor:   8.551


  29 in total

1.  Participation of eosinophils in the toxic oil syndrome.

Authors:  R M Ten; G M Kephart; M Posada; I Abaitua; L Soldevilla; E M Kilbourne; S L Dunnette; G J Gleich
Journal:  Clin Exp Immunol       Date:  1990-11       Impact factor: 4.330

2.  Extracellular Eosinophil Granule Protein Deposition in Ringed Esophagus with Sparse Eosinophils.

Authors:  Kathryn A Peterson; William J Cobell; Frederic C Clayton; Chaya Krishnamurthy; Jian Ying; Leonard F Pease; Hedieh Saffari; Ann Georgelas; John Fang; Gerald J Gleich; Kristin M Leiferman
Journal:  Dig Dis Sci       Date:  2015-04-23       Impact factor: 3.199

3.  Comparative immunoreactivity of the eosinophil constituents MBP and ECP in different types of urticaria.

Authors:  N Haas; K Motel; B M Czarnetzki
Journal:  Arch Dermatol Res       Date:  1995       Impact factor: 3.017

4.  Deposition of eosinophil granule proteins precedes blister formation in bullous pemphigoid. Comparison with neutrophil and mast cell granule proteins.

Authors:  L Borrego; B Maynard; E A Peterson; T George; L Iglesias; M S Peters; W Newman; G J Gleich; K M Leiferman
Journal:  Am J Pathol       Date:  1996-03       Impact factor: 4.307

5.  Effects of an Oral CRTh2 Antagonist (AZD1981) on Eosinophil Activity and Symptoms in Chronic Spontaneous Urticaria.

Authors:  Eric Tyrell Oliver; Kris Chichester; Kelly Devine; Patricia Meghan Sterba; Craig Wegner; Becky Marie Vonakis; Sarbjit Singh Saini
Journal:  Int Arch Allergy Immunol       Date:  2019-03-15       Impact factor: 2.749

6.  Bioactivity of autologous irradiated renal cell carcinoma vaccines generated by ex vivo granulocyte-macrophage colony-stimulating factor gene transfer.

Authors:  J W Simons; E M Jaffee; C E Weber; H I Levitsky; W G Nelson; M A Carducci; A J Lazenby; L K Cohen; C C Finn; S M Clift; K M Hauda; L A Beck; K M Leiferman; A H Owens; S Piantadosi; G Dranoff; R C Mulligan; D M Pardoll; F F Marshall
Journal:  Cancer Res       Date:  1997-04-15       Impact factor: 12.701

7.  Localization of eosinophil major basic protein onto eggs of Schistosoma mansoni in human pathologic tissue.

Authors:  G M Kephart; Z A Andrade; G J Gleich
Journal:  Am J Pathol       Date:  1988-11       Impact factor: 4.307

8.  Inflammatory cells in the airways in mild asthma.

Authors:  S Lozewicz; E Gomez; H Ferguson; R J Davies
Journal:  BMJ       Date:  1988-12-10

9.  Alteration in the density, morphology, and biological properties of eosinophils produced by bullous pemphigoid blister fluid.

Authors:  M Miyasato; S Tsuda; M Kasada; K Iryo; Y Sasai
Journal:  Arch Dermatol Res       Date:  1989       Impact factor: 3.017

10.  Human eosinophil major basic protein augments bronchoconstriction induced by intravenous agonists in guinea pigs.

Authors:  S N Desai; G Van; J Robson; L G Letts; R H Gundel; G J Gleich; P J Piper; T C Noonan
Journal:  Agents Actions       Date:  1993
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.